THROMBOTROL®-VF

Antithrombin III Concentrate (Human)

For more information about THROMBOTROL-VF, please visit the New Zealand Blood Servicewebsite.
For information on how to prepare THROMBOTROL-VF using the Mix2Vial™
THROMBOTROL-VF is a freeze-dried preparation of human antithrombin III.

THROMBOTROL-VF contains antithrombin III, which is a protein normally present in the blood, that prevents the formation of blood clots.

THROMBOTROL-VF may be administered, as a preventative measure, prior to surgery or during pregnancy and childbirth in patients with an inherited deficiency of antithrombin III. Such patients may be at risk of spontaneous thrombosis (blood clots) or pulmonary embolism (blood clot which stops blood circulating through the lungs). The risk of these conditions increases with age and in association with surgery, pregnancy and childbirth. THROMBOTROL-VF increases antithrombin III levels in the blood and thereby decreases the risk of blood clots.

THROMBOTROL-VF is supplied as a freeze-dried powder which is dissolved with Water for Injections and then injected into a vein. Each vial of THROMBOTROL-VF is packaged with one vial of Water for Injections and a plastic Mix2Vial™ filter transfer set that is used to transfer the Water for Injections into the THROMBOTROL-VF vial.

THROMBOTROL-VF is available only with a doctor’s prescription.


Data sheet
The data sheet contains information to ensure the safe and effective use of a medicine. This document is approved by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. It is made available by CSL Behring for you if you are a:
  1. qualified healthcare professional; or
  2. consumer wanting further information on the product; and agree to consult with your healthcare professional if you have any questions in relation to the Data sheet.
PDF icon THROMBOTROL-VF Data Sheet (PDF, 0.15MB)

® Registered Trademark of CSL Limited, ™ Trade mark of Medimop Medical Projects Ltd

Last Updated: 26/03/2014
© 2016 CSL Limited